Alpha Cognition Inc. (ACOG)
NASDAQ: ACOG · Real-Time Price · USD
5.87
+0.08 (1.38%)
At close: Mar 9, 2026, 4:00 PM EDT
5.87
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:00 PM EDT
Alpha Cognition Market Cap
Alpha Cognition has a market cap or net worth of $129.58 million as of March 9, 2026. Its market cap has increased by 28.40% in one year.
Market Cap
129.58M
Enterprise Value
90.49M
1-Year Change
28.40%
Ranking
Category
Stock Price
$5.87
Market Cap Chart
Since June 28, 2021, Alpha Cognition's market cap has increased from $33.63M to $129.58M, an increase of 285.29%. That is a compound annual growth rate of 33.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 125.89M | -10.92% |
| Dec 31, 2025 | 141.32M | 49.78% |
| Dec 31, 2024 | 94.36M | 60.66% |
| Dec 29, 2023 | 58.73M | 350.37% |
| Dec 30, 2022 | 13.04M | -78.27% |
| Dec 31, 2021 | 60.00M | 78.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adagene | 133.85M |
| Oramed Pharmaceuticals | 130.75M |
| Polaryx Therapeutics | 129.72M |
| Spero Therapeutics | 129.58M |
| Cardiff Oncology | 128.53M |
| Aardvark Therapeutics | 127.37M |
| Black Diamond Therapeutics | 122.50M |
| Genelux | 120.01M |